![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 2854N
GW Pharmaceuticals PLC
28 January 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or GW PHARMACEUTICALS PLC the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ------------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ --------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ --------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ --------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------ --------------------------------- Other (please specify): --------------------------------------------------------- ------- --------------------------------- 3. Full name of person(s) The Bank of New York Mellon subject to the Corporation notification obligation: (iii) ----------------------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) The Bank of New York Mellon; (if different from 3.):(iv) The Dreyfus Corporation; The Boston Company Asset Management LLC; BNY Mellon, National Association; BNY Mellon Capital Markets, LLC. ----------------------------------------------------------- ---------------------------------------- 5. Date of the transaction 26 January 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ---------------------------------------- 6. Date on which issuer 27 January 2016 notified: ----------------------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are Crossing above 5% crossed or reached: (vi, vii) ----------------------------------------------------------- ---------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- --------------------------------- ---------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- ---------------- ------------- --------------------------- -------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ------------ ------------- -------------- ----------- ------------- ----------- Common Stock 11,862 11,862 11,862 11,862 N/A 0.0045% N/A GB0030544687 ADR 1,076,351 12,916,212 1,165,618 13,987,416 N/A 5.3270% N/A --------------- ---------------- ------------- -------------- ----------- ------------- ----------- US36197T1034 ------------- ----------- ------------ ----------- ------------ ----------- --------- --------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------- ----------------------------- ---------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- -------------- --------------- ----------------------------- ------------------------ Nominal Delta --------------- ------------- -------------- --------------- ----------------------------- ------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights -------------------------------------------------- -------------------------------------------------------------------- 13,999,278 5.33% -------------------------------------------------- -------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------- The Bank of New York Mellon Corporation is making this disclosure as the ultimate parent company of: The Bank of New York Mellon; The Dreyfus Corporation; The Boston Company Asset Management LLC; BNY Mellon, National Association and BNY Mellon Capital Markets, LLC. Proxy Voting: ---------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------------ -------------- 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------------------------------ -------------- 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------------------------------ -------------- 13. Additional information: N/A ------------------------------------------------------------ -------------- 14. Contact name: Andrew Weiser ------------------------------------------------------------ -------------- 15. Contact telephone number: 516-338-3752 ------------------------------------------------------------ --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPFPALKKEEF
(END) Dow Jones Newswires
January 28, 2016 03:47 ET (08:47 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions